Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | More
 
or
Watchlist | Portfolio
Site News
Contact
Market:

Pavmed Inc (PAVM)

Pavmed Inc (PAVM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
PAVmed and Lucid Diagnostics to Participate in Panel Presentation at the 2023 Cantor Fitzgerald Global Healthcare Conference PR Newswire - Thu Sep 21, 2023

/PRNewswire/ -- PAVmed Inc. (Nasdaq: PAVM, PAVMZ) ("PAVmed"), a diversified commercial-stage medical technology company operating in the medical device,...

PAVM : 2.07 (-7.59%)
LUCD : 0.9297 (-2.14%)
Lucid Diagnostics Releases Positive Data from First Prospective Clinical Utility Study of EsoGuard® Esophageal Precancer Detection PR Newswire - Thu Sep 7, 2023

/PRNewswire/ -- Lucid Diagnostics Inc. (Nasdaq: LUCD) ("Lucid" or the "Company") a commercial-stage, cancer prevention medical diagnostics company, and...

PAVM : 2.07 (-7.59%)
LUCD : 0.9297 (-2.14%)
PAVmed Provides Business Update and Second Quarter Financial Results PR Newswire - Tue Aug 15, 2023

/PRNewswire/ -- PAVmed Inc. (NASDAQ: PAVM, PAVMZ) ("PAVmed" or the "Company"), a diversified commercial-stage medical technology company, operating in the...

PAVM : 2.07 (-7.59%)
LUCD : 0.9297 (-2.14%)
Lucid Diagnostics Provides Business Update and Second Quarter Financial Results PR Newswire - Mon Aug 14, 2023

/PRNewswire/ -- Lucid Diagnostics Inc. (Nasdaq: LUCD) ("Lucid" or the "Company") a commercial-stage, cancer prevention medical diagnostics company, and...

LUCD : 0.9297 (-2.14%)
PAVM : 2.07 (-7.59%)
PAVmed to Hold a Business Update Conference Call and Webcast on August 16, 2023 PR Newswire - Mon Jul 31, 2023

/PRNewswire/ -- PAVmed Inc. (Nasdaq: PAVM, PAVMZ) ("PAVmed" or the "Company"), a diversified commercial-stage medical technology company, operating in the...

PAVM : 2.07 (-7.59%)
LUCD : 0.9297 (-2.14%)
Lucid Diagnostics to Hold a Business Update Conference Call and Webcast on August 15, 2023 PR Newswire - Mon Jul 31, 2023

/PRNewswire/ -- Lucid Diagnostics Inc. (Nasdaq: LUCD) ("Lucid" or the "Company") a commercial-stage, cancer prevention medical diagnostics company and...

PAVM : 2.07 (-7.59%)
LUCD : 0.9297 (-2.14%)
Lucid Diagnostics to Present at the Canaccord Genuity 43rd Annual Growth Conference PR Newswire - Wed Jul 26, 2023

/PRNewswire/ -- Lucid Diagnostics Inc. (Nasdaq: LUCD) ("Lucid Diagnostics" or "Lucid"), a commercial-stage cancer prevention diagnostics company and a...

PAVM : 2.07 (-7.59%)
LUCD : 0.9297 (-2.14%)
PAVmed and Lucid Chairman and Chief Executive Officer, Dr. Lishan Aklog, Testifies at U.S. House of Representatives Energy and Commerce Committee, Hearing on Life-Saving Innovations and Medicare Coverage PR Newswire - Wed Jul 19, 2023

/PRNewswire/ -- PAVmed Inc. (NASDAQ: PAVM, PAVMZ) ("PAVmed"), a diversified commercial-stage medical technology company, operating in the medical device,...

PAVM : 2.07 (-7.59%)
LUCD : 0.9297 (-2.14%)
PAVmed Receives 180-Day Extension to Regain Compliance with Nasdaq Minimum Bid Price Requirement PR Newswire - Wed Jun 28, 2023

/PRNewswire/ -- PAVmed Inc. (NASDAQ: PAVM, PAVMZ) ("PAVmed" or the "Company"), a diversified commercial-stage medical technology company, operating in the...

PAVM : 2.07 (-7.59%)
LUCD : 0.9297 (-2.14%)
PAVmed to Participate in Healthcare Virtual Conference Presented by Maxim Group LLC PR Newswire - Wed Jun 14, 2023

/PRNewswire/ -- PAVmed Inc. (NASDAQ: PAVM, PAVMZ) ("PAVmed" or the "Company"), a diversified commercial-stage medical technology company operating in the...

PAVM : 2.07 (-7.59%)
LUCD : 0.9297 (-2.14%)

Barchart Exclusives

Tesla Stock Put Options Are Still Highly Priced - Ideal for Shareholders to Sell Short for Income Barchart - 1 hour ago
Tesla Inc. put options in near-term expiry periods are still at high premium levels, even after TSLA stock has rebounded. This is ideal for existing shareholders to sell short to gain extra income. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot